Revenue: HKD 1,584,912; YoY change: -68.77%; QoQ change: -34.31% (HKD). Gross Profit: HKD -299,509; Gross Margin: -18.90% (negative); YoY Gross Profit change: -119.65%; QoQ: -137.88%. Operating Income: HKD -8,636,140; Operating Margin: -5.45%. EBITDA: HKD -8,631,974; EBITDA Margin: -5.45% (consistent with operating loss given revenue mix). Net Income: HKD -8,677,022; Net Margin: -5.47%. EPS: -0.74; Diluted EPS: -0.74; Weighted Avg Shares: 11,695,407.
Liquidity and cash flow: Net cash from operating activities: HKD -60,508; Net cash used in financing activities: HKD -333,124; Net change in cash: HKD -384,963; Cash at end of period: HKD 143,699; Cash and cash equivalents: HKD 18,359. Balance sheet health: Total assets HKD 477,088; Total liabilities HKD 757,666; Shareholders’ equity HKD -280,577 (negative). Current ratio reported: 8.54 (reflecting a liquidity buffer on current liabilities but not addressing solvency concerns). Receivables turnover and other liquidity metrics suggest limited near-term cash generation potential.
Key observations: (i) Revenue contraction amid outsized operating costs; (ii) Persistent negative margins and large SG&A spend; (iii) Negative equity and modest cash reserve implying potential need for external capital or restructuring; (iv) No disclosed peer comparables or benchmarks in the provided data.